Evidence map›Paper›PMID 24053355›Full record

ArticleBiochemistry2013

First three-dimensional structure of Toxoplasma gondii thymidylate synthase-dihydrofolate reductase: insights for catalysis, interdomain interactions, and substrate channeling.

Hitesh Sharma, Mark J Landau, Melissa A Vargo, Krasimir A Spasov, Karen S Anderson

Abstract read
In one paragraph

Article in Biochemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Evaluation ofMetabolites · 2022
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Discovery of Potent and Selective Leads againstACS medicinal chemistry letters · 2016
    Article
  12. Review
  13. Article
  14. Substrate channeling between the human dihydrofolate reductase and thymidylate synthase.Protein science : a publication of the Protein Society · 2016
    Article
  15. Article
  16. Article
  17. Article
  18. Discovery of potent and selective inhibitors ofACS medicinal chemistry letters · 2013
    Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Hitesh Sharma *The Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06510.
Mark J Landau *The Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06510.
Melissa A VargoThe Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06510.
Krasimir A SpasovThe Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06510.
Karen S AndersonThe Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06510.
Yale University · US

Funding

Predoc Training at the Interface Chemistry and BiologyT32GM067543 · NIGMS · YALE UNIVERSITY · PI CRAWFORD, JASON MICHAEL · 2003 to 2022
$7.4M
Exploring Novel Targeting Strategies for AIDS Protozoal PathogensR01AI083146 · NIAID · YALE UNIVERSITY · PI ANDERSON, KAREN S. · 2010 to 2019
$3.9M
Exploring Novel Targeting Strategies for AIDS Protozoal PathogensR56AI083146 · NIAID · YALE UNIVERSITY · PI ANDERSON, KAREN S. · 2009 to 2009
$414k
NIAID NIH HHS AI 083146NIAID NIH HHS R01 AI083146NIAID NIH HHS R56 AI083146NIGMS NIH HHS 5 T32 GM067543NIGMS NIH HHS T32 GM067543
6 · The paper itself

Abstract

Most species, such as humans, have monofunctional forms of thymidylate synthase (TS) and dihydrofolate reductase (DHFR) that are key folate metabolism enzymes making critical folate components required for DNA synthesis. In contrast, several parasitic protozoa, including Toxoplasma gondii , contain a unique bifunctional thymidylate synthase-dihydrofolate reductase (TS-DHFR) having the catalytic activities contained on a single polypeptide chain. The prevalence of T. gondii infections across the world, especially for those immunocompromised, underscores the need to understand TS-DHFR enzyme function and to find new avenues to exploit for the design of novel antiparasitic drugs. As a first step, we have solved the first three-dimensional structures of T. gondii TS-DHFR at 3.7 Å and of a loop truncated TS-DHFR, removing several flexible surface loops in the DHFR domain, improving resolution to 2.2 Å. Distinct structural features of the TS-DHFR homodimer include a junctional region containing a kinked crossover helix between the DHFR domains of the two adjacent monomers, a long linker connecting the TS and DHFR domains, and a DHFR domain that is positively charged. The roles of these unique structural features were probed by site-directed mutagenesis coupled with presteady state and steady state kinetics. Mutational analysis of the crossover helix region combined with kinetic characterization established the importance of this region not only in DHFR catalysis but also in modulating the distal TS activity, suggesting a role for TS-DHFR interdomain interactions. Additional kinetic studies revealed that substrate channeling occurs in which dihydrofolate is directly transferred from the TS to DHFR active site without entering bulk solution. The crystal structure suggests that the positively charged DHFR domain governs this electrostatically mediated movement of dihydrofolate, preventing release from the enzyme. Taken together, these structural and kinetic studies reveal unique, functional regions on the T. gondii TS-DHFR enzyme that may be targeted for inhibition, thus paving the way for designing species specific inhibitors.

Indexed as

Binding SitesCatalysisCatalytic DomainFolic AcidImaging, Three-DimensionalKineticsModels, MolecularMultienzyme ComplexesProtein Structure, SecondaryProtozoan ProteinsSubstrate SpecificityTetrahydrofolate DehydrogenaseThymidylate SynthaseToxoplasmaFolic AcidMultienzyme ComplexesProtozoan ProteinsTetrahydrofolate DehydrogenaseThymidylate Synthasethymidylate synthase-dihydrofolate reductase

Identifiers

PMID24053355
PMCPMC3905773
OpenAlexW2058147543

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.